HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 5.840
  • -0.370-5.96%
Not Open May 6 16:08 CST
67.42BMarket Cap14.42P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
-7.76%29.01B
-4.94%22.69B
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
Operating income
-7.76%29.01B
-4.94%22.69B
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
Cost of sales
6.07%-8.71B
5.26%-6.7B
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
Operating expenses
6.07%-8.71B
5.26%-6.7B
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
Gross profit
-8.47%20.3B
-4.80%15.99B
3.71%11.65B
17.70%6.5B
-0.36%22.18B
-1.70%16.79B
-0.89%11.24B
-5.03%5.52B
5.31%22.26B
9.11%17.08B
Selling expenses
5.23%-8.66B
5.79%-6.62B
2.55%-4.78B
-18.97%-2.96B
11.58%-9.14B
13.34%-7.03B
9.39%-4.9B
11.91%-2.49B
1.01%-10.34B
-4.32%-8.11B
Administrative expenses
9.25%-1.08B
-2.88%-880.65M
-18.15%-632.84M
-26.51%-332.83M
-1.43%-1.19B
2.08%-855.97M
5.17%-535.64M
-1.07%-263.08M
-16.14%-1.17B
-16.82%-874.16M
Research and development expenses
-7.46%-5.19B
-5.49%-3.88B
-10.35%-2.54B
-16.04%-1.17B
-21.17%-4.83B
-25.95%-3.68B
-22.27%-2.3B
-11.77%-1.01B
-16.14%-3.99B
-16.43%-2.92B
Profit from asset sales
----
----
----
----
--32.86M
----
----
----
----
----
Special items of operating profit
-17.80%345.73M
-36.05%259.57M
-19.70%172.47M
41.09%59.06M
-48.38%420.59M
-8.36%405.88M
-13.72%214.78M
164.60%41.86M
49.32%814.85M
-22.03%442.91M
Operating profit
-23.53%5.71B
-13.72%4.86B
4.42%3.87B
16.13%2.09B
-1.39%7.47B
0.27%5.63B
-0.47%3.71B
2.37%1.8B
11.47%7.57B
8.24%5.62B
Financing cost
-68.65%-43.67M
-97.26%-33.29M
-104.95%-21.98M
-37.84%-6.11M
-4.04%-25.9M
-12.51%-16.88M
-10.29%-10.72M
-54.97%-4.43M
-224.78%-24.89M
-132.70%-15M
Share of profits of associates
-11.83%-45.92M
-19.90%-39.53M
-67.65%-27.24M
-24.61%-15.01M
3.40%-41.07M
29.06%-32.97M
39.72%-16.25M
-42.31%-12.05M
-77.91%-42.51M
-119.94%-46.48M
Share of profit from joint venture company
-231.67%-43.55M
-653.04%-41.44M
-983.37%-24.43M
-187.38%-13.48M
-148.43%-13.13M
-113.24%-5.5M
-108.12%-2.26M
-131.76%-4.69M
-41.49%27.11M
15.51%41.56M
Special items of earning before tax
----
----
----
----
----
--32.86M
----
----
28.64%48.07M
----
Earning before tax
-24.50%5.58B
-15.41%4.75B
3.25%3.8B
15.57%2.06B
-2.54%7.39B
0.23%5.61B
-1.02%3.68B
0.97%1.78B
10.74%7.58B
7.18%5.6B
Tax
5.83%-1.24B
2.28%-942.7M
-20.23%-749.66M
-37.35%-428.35M
2.48%-1.32B
5.98%-964.74M
9.95%-623.51M
5.39%-311.86M
-16.50%-1.35B
-24.40%-1.03B
After-tax profit from continuing operations
-28.55%4.34B
-18.13%3.8B
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
Earning after tax
-28.55%4.34B
-18.13%3.8B
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
Minority profit
-94.59%10.79M
-83.53%24.77M
-65.85%31.09M
-57.68%17.04M
41.74%199.37M
45.84%150.38M
49.57%91.05M
35.22%40.26M
69.59%140.66M
66.96%103.11M
Profit attributable to shareholders
-26.31%4.33B
-15.94%3.78B
1.80%3.02B
12.88%1.61B
-3.58%5.87B
0.60%4.49B
0.03%2.97B
1.73%1.43B
8.67%6.09B
3.06%4.47B
Basic earnings per share
-25.47%0.3687
-15.35%0.3203
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.93%0.3784
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
Diluted earnings per share
-25.47%0.3687
-15.33%0.3203
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.91%0.3783
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover -7.76%29.01B-4.94%22.69B1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B
Operating income -7.76%29.01B-4.94%22.69B1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B
Cost of sales 6.07%-8.71B5.26%-6.7B4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B
Operating expenses 6.07%-8.71B5.26%-6.7B4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B
Gross profit -8.47%20.3B-4.80%15.99B3.71%11.65B17.70%6.5B-0.36%22.18B-1.70%16.79B-0.89%11.24B-5.03%5.52B5.31%22.26B9.11%17.08B
Selling expenses 5.23%-8.66B5.79%-6.62B2.55%-4.78B-18.97%-2.96B11.58%-9.14B13.34%-7.03B9.39%-4.9B11.91%-2.49B1.01%-10.34B-4.32%-8.11B
Administrative expenses 9.25%-1.08B-2.88%-880.65M-18.15%-632.84M-26.51%-332.83M-1.43%-1.19B2.08%-855.97M5.17%-535.64M-1.07%-263.08M-16.14%-1.17B-16.82%-874.16M
Research and development expenses -7.46%-5.19B-5.49%-3.88B-10.35%-2.54B-16.04%-1.17B-21.17%-4.83B-25.95%-3.68B-22.27%-2.3B-11.77%-1.01B-16.14%-3.99B-16.43%-2.92B
Profit from asset sales ------------------32.86M--------------------
Special items of operating profit -17.80%345.73M-36.05%259.57M-19.70%172.47M41.09%59.06M-48.38%420.59M-8.36%405.88M-13.72%214.78M164.60%41.86M49.32%814.85M-22.03%442.91M
Operating profit -23.53%5.71B-13.72%4.86B4.42%3.87B16.13%2.09B-1.39%7.47B0.27%5.63B-0.47%3.71B2.37%1.8B11.47%7.57B8.24%5.62B
Financing cost -68.65%-43.67M-97.26%-33.29M-104.95%-21.98M-37.84%-6.11M-4.04%-25.9M-12.51%-16.88M-10.29%-10.72M-54.97%-4.43M-224.78%-24.89M-132.70%-15M
Share of profits of associates -11.83%-45.92M-19.90%-39.53M-67.65%-27.24M-24.61%-15.01M3.40%-41.07M29.06%-32.97M39.72%-16.25M-42.31%-12.05M-77.91%-42.51M-119.94%-46.48M
Share of profit from joint venture company -231.67%-43.55M-653.04%-41.44M-983.37%-24.43M-187.38%-13.48M-148.43%-13.13M-113.24%-5.5M-108.12%-2.26M-131.76%-4.69M-41.49%27.11M15.51%41.56M
Special items of earning before tax ----------------------32.86M--------28.64%48.07M----
Earning before tax -24.50%5.58B-15.41%4.75B3.25%3.8B15.57%2.06B-2.54%7.39B0.23%5.61B-1.02%3.68B0.97%1.78B10.74%7.58B7.18%5.6B
Tax 5.83%-1.24B2.28%-942.7M-20.23%-749.66M-37.35%-428.35M2.48%-1.32B5.98%-964.74M9.95%-623.51M5.39%-311.86M-16.50%-1.35B-24.40%-1.03B
After-tax profit from continuing operations -28.55%4.34B-18.13%3.8B-0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B
Earning after tax -28.55%4.34B-18.13%3.8B-0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B
Minority profit -94.59%10.79M-83.53%24.77M-65.85%31.09M-57.68%17.04M41.74%199.37M45.84%150.38M49.57%91.05M35.22%40.26M69.59%140.66M66.96%103.11M
Profit attributable to shareholders -26.31%4.33B-15.94%3.78B1.80%3.02B12.88%1.61B-3.58%5.87B0.60%4.49B0.03%2.97B1.73%1.43B8.67%6.09B3.06%4.47B
Basic earnings per share -25.47%0.3687-15.35%0.32032.24%0.255113.51%0.1361-3.21%0.49470.93%0.37840.24%0.24951.70%0.11999.00%0.51113.39%0.3749
Diluted earnings per share -25.47%0.3687-15.33%0.32032.24%0.255113.51%0.1361-3.21%0.49470.91%0.37830.24%0.24951.70%0.11999.00%0.51113.39%0.3749
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion------Unqualified Opinion------Unqualified Opinion--
Auditor Deloitte Guan Huang Chen Fang Certified Public Accountants------Deloitte Guan Huang Chen Fang Certified Public Accountants------Deloitte Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol 5D % Chg
Sample Name
Sample Code
 +5.45%
Sample Name
Sample Code
 +5.05%
Sample Name
Sample Code
 +4.57%
4
Charter Communications
CHTR
+4.06%
5
MasterCard
MA
+3.58%
Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More
Berkshire's 2025 Annual Shareholders Meeting

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -